Haleh Amirian, MD, MS

Post-Doc
University of Miami School of Medicine - Miami, FL, Florida, United States

-09/2007 - 11/2014 M.D., Mashhad University of Medical Sciences, Mashhad, Iran
-09/2017 – 04/2019 M.S., Clinical Research, Rush University, Chicago, IL
-06/2019-06/2021 General Surgery Resident, University of Miami/Jackson Memorial Program
-07/2021-Present Postdoctoral Associate, Department of Surgery, University of Miami
-----------------------------------------------------------------------------------------------------------------------
--------- --------- ------------ -------- ---------- ----------- ------------- ------------- ------------- ---------------

Presentation(s):

• 46: A novel mechanism of immunotherapy sensitivity following platinum chemotherapy resistance in pancreatic cancer patients with germline homologous recombination deficiency

  Thursday, March 21, 2024
  2:42pm – 2:52pm ET

• P32: JNK inhibition reprograms the tumor-immune-microenvironment to overcome chemoresistance in PDAC

  Friday, March 22, 2024
  11:43am – 11:49am ET

• 56: Disrupting TNFR2 Signaling Improves Chemotherapy sensitivity in Pancreatic Cancer

  Saturday, March 23, 2024
  9:02am – 9:12am ET